Reports of mixed signals from the Food and Drug Administration about a prominent genetic test they just approved and promote lack clarity that could jeopardize Americans’ health. 23andMe is simple to use reports the San Francisco Chronicle. Individuals order it online, submit the samples and within a couple of weeks 23andMe analyzes their DNA for nearly three dozen genetic variants. These predict how consumers would metabolize commonly prescribed drugs such as antidepressants and blood thinners. However, there are a growing number of challenges. For example, Christine Stanislaw, director of genetic counseling at the Winship Cancer Institute of Emory University, warned that direct-to-consumer tests are generally “less likely to be able to predict your chances of developing a health problem.” Follow the link below to read more.